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Abstract 
According to the current guidelines of the Polish Society of Hypertension on the management of primary aldo-
steronism (PA) associated with aldosterone-producing adenoma, the treatment of choice is unilateral laparoscopic 
adrenalectomy. Isolated deficiency of aldosterone after adrenalectomy for Conn’s syndrome is rare. The literature 
finds few reports on postoperative hypoaldosteronism requiring mineralocorticoid replacement. In this case study 
we present a patient who developed postoperative hypoaldosteronism.
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Case study
A 56-year-old patient with long-standing history of 
hypertension, hypokalaemia, and left adrenal gland 
tumour was admitted to the Department of Hyper-
tension for the hormonal diagnosis. On physical 
examination, there were no significant deviations. 
Performed laboratory tests revealed hypokalaemia 
of 2.07 mmol/l (normal range 3.5−5.5 mmol/l) and 
hypercholesterolaemia of 285 mg/dl (normal range 
up to 200 mg/dl). Her baseline aldosterone level was 
341 pg/ml (normal range 10−160 pg/ml), plasma 
renin activity (PRA) was 0.97 ng/ml/h (normal range 
0.51−2.64), aldosterone/rennin ratio (ARR) was 
35.2 with a positive saline suppression test (post sa-
line aldosterone 190 pg/ml, plasma renin activity of 
0.53 ng/ml/h, ARR 35.8). Mean arterial pressure in 
24-hour ambulatory blood pressure monitoring was 
156/94 mm Hg. CT scan confirmed the left adrenal 
tumour size 1.6 × 1.4 × 1.7 cm, classified as adenoma 
(Figure 1). Perindopril and spironolactone was im-
plemented to the antihypertensive treatment. Having 
regard to the entire clinical picture, the patient was 
diagnosed with Conn’s  syndrome. She was referred 
for surgical management and discharged home on the 
third postoperative day with the recommendation of 
the continuation of current antihypertensive therapy 
except for spironolactone. After two months the pa-
tient came to the emergency room with complaints 
of weakness, headaches, and low blood pressure 
(BP) measurements at home, oscillating around 90/ 
/60 mm Hg. Laboratory tests revealed hyperkalaemia 
of 5.67 mmol/l and decreased level of sodium of 132 
mmol/l (normal range 135–145 mmol/l). During 
hospitalization, she was diagnosed with aldosterone 
deficiency and started on aldosterone replacement 
therapy with fludrocortisone. Normalization of ion 
levels and BP was observed as a result of treatment.
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Discussion
According to the current guidelines of the Polish 
Society of Hypertension on the management of pri-
mary aldosteronism (PA) associated with aldoste-
rone-producing adenoma, the treatment of choice is 
unilateral laparoscopic adrenalectomy [1]. The lite-
rature finds few reports on postoperative hypoaldo-
steronism requiring mineralocorticoid replacement 
[2–6]. Literature data indicate that some patients 
who undergo adrenalectomy for PA present postope-
rative hyperkalaemia associated with the inability of 
the remaining adrenal gland to compensatory aldo-
sterone production [2, 7, 8].
In 2010, Huang et al. reported a case of 62-year-
old man with severe hyperkalaemia after adrenalec-
tomy — laboratory tests showed a high level of PRA 
and low level of aldosterone, normal levels of corti-
sol and ACTH suggesting hypoaldosteronism as the 
cause of hypokalaemia [3]. Similarly, in 2015, Yorke 
et al. described a case of 66-year-old female operated 
for Conn’s syndrome, with subsequent postoperative 
hyperkalaemia and hypotension, successfully treated 
with fludrocortisone [2]. 
As reported by Gadallah et al., the gradual nor-
malization of hyperkalaemia and the aldosterone 
level meant this suppression is reversible [5]. In fact, 
some studies suggest that postoperative deficiency of 
aldosterone is temporary and aldosterone level is nor-
malized within approximately six months [6, 9–11]. 
In opposition, Gordon et al. suggest that untreated 
hypoaldosteronism may not subside spontaneously 
and their opinion is based on a  prospective study 
of a  group of 26 patients after adrenalectomy for 
Conn’s  syndrome, among whom, in the two-year 
follow-up period, 27% had a systolic blood pressure 
Figure 1. The patient’s CT scan
below the fifth percentile, which was associated with 
aldosterone deficiency [4].
The literature describes the heterogeneous data on 
the relationship between preoperative spironolactone 
therapy and postoperative aldosterone deficiency. 
Morimoto et al. suggest that the pretreatment with spi-
ronolactone promotes the normalization of the juxta-
glomerular apparatus function postoperatively [12]. 
In contrast, Fisher et al. indicate that preoperational 
spironolactone therapy has no impact on the inci-
dence of subsequent hypoaldosteronism. Based on 
their own study, they described age and impaired 
renal function as the risk factors [13].
In summary, the reports of aldosterone deficiency 
after adrenalectomy for Conn’s syndrome emphasize 
the role of the recovery control in these patients, in 
particular the elderly and those with impaired renal 
function.
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